"CONCLUSIONS
Idarucizumab completely reversed the anticoagulant effect of dabigatran within minutes. (Funded by Boehringer Ingelheim; RE-VERSE AD ClinicalTrials.gov number, NCT02104947.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1502000?query=featured_home
No comments:
Post a Comment